Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Biovica International AB (publ)
BIOVIC-BCurrent price
2.6 SEK
-0.065 SEK (-2.44%)
Last closed
2.65 SEK
Company
www.biovica.com
ISIN
SE0008613731
Sector
Healthcare
Industry
Biotechnology
Exchange
Stockholm Exchange
Capitalization
238 913 919 SEK
Yield for 12 month
-65.01 %
1Y
3Y
5Y
10Y
15Y
BIOVIC-B
Biovica International AB (publ), a biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the United States of America. It primarily focuses on breast cancer. The company develops DiviTum TKa, a blood-based biomarker assay that measures thymidine kinase activity, which is correlated with cell proliferation. It serves cancer institutes, pharmaceutical companies, and collaborative groups. Biovica International AB (publ) was incorporated in 2008 and is headquartered in Uppsala, Sweden. Address: Dag Hammarskjölds väg 54B, Uppsala, Sweden, 752 37
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
232.83 SEKP/E ratio
–Dividend Yield
–Current Year
+7 288 510 SEK
Last Year
+3 383 311 SEK
Current Quarter
+1 898 617 SEK
Last Quarter
+1 074 777 SEK
Current Year
-120 960 346 SEK
Last Year
+4 616 058 SEK
Current Quarter
-41 469 547 SEK
Last Quarter
+771 846 SEK
Key Figures BIOVIC-B
1 year
3 years
5 years
10 years
EBITDA
-126 521 211 SEK
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-52.53 %
PEG Ratio
–
Return On Equity TTM
-106.11 %
Wall Street Target Price
232.83 SEK
Revenue TTM
7 293 513 SEK
Book Value
1.15 SEK
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
20.9 %
Dividend Yield
–
Gross Profit TTM
4 869 007 SEK
Earnings per share
-2.14 SEK
Diluted Eps TTM
-2.14 SEK
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics BIOVIC-B
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BIOVIC-B
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation BIOVIC-B
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
13.6986
Enterprise Value Revenue
22.403
Price Sales TTM
32.757
Enterprise Value EBITDA
-8.749
Price Book MRQ
2.4306
Financials BIOVIC-B
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators BIOVIC-B
For 52 weeks
1.49 SEK
8.39 SEK
50 Day MA
2.66 SEK
Shares Short Prior Month
–
200 Day MA
2.43 SEK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart